Successful Treatment of Recalcitrant Hidradenitis Suppurativa with Adalimumab
Hidradenitis suppurativa is a chronic disease that affects the apocrine gland-bearing regions of the body. The etiology of this disorder is poorly understood, but most likely is a complex process involving follicular apocrine occlusion with subsequent perifolliculitis. Many treatment options have be...
Main Authors: | Ian Gorovoy, Adar Berghoff, Laura Ferris |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2009-10-01
|
Series: | Case Reports in Dermatology |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/251217 |
Similar Items
-
Management of severe hidradenitis suppurativa with biologic therapy and wide excision
by: Shi Yu Derek Lim, et al.
Published: (2019-05-01) -
Paradoxical Hidradenitis Suppurativa during Biologic Therapy, an Emerging Challenge: A Systematic Review
by: Angelo Ruggiero, et al.
Published: (2022-02-01) -
Spotlight on adalimumab in the treatment of active moderate-to-severe hidradenitis suppurativa
by: Fotiadou C, et al.
Published: (2016-10-01) -
Immune Dysregulation and Current Targeted Biologics in Hidradenitis Suppurativa
by: Rene Chen, et al.
Published: (2024-02-01) -
Two Cases of Paradoxical Hidradenitis Suppurativa while on Adalimumab
by: Glenn Harvin, et al.
Published: (2016-05-01)